EverHint – EMA10 x EMA30 Crossover Signals for Jan 09, 2026 – Healthcare Leads with 20 Setups
What This Signal Is (Quick)
EMA10 x EMA30 Crossover detects fresh crossovers between the 10-day and 30-day exponential moving averages.
Buy signals occur when EMA10 crosses above EMA30, indicating short-term momentum overtaking the medium-term trend.
Sell signals occur when EMA10 crosses below EMA30, suggesting momentum weakening. More responsive than SMA-based
crossovers, better suited for capturing short-to-medium term momentum shifts in swing trading.
Key Criteria:
-
Buy: EMA10 crosses above EMA30
-
Sell: EMA10 crosses below EMA30
-
Minimum ADV: $40M (liquidity filter)
-
Earnings buffer: 7 days pre/post earnings
-
Fresh crossover: Detected on today's close
Holding Period: 1-4 weeks
Risk Level: Medium
How We Ranked Today
Ranked by RSI (lower RSI for buy signals = more oversold)
How We Ranked Today (Reader Version)
Ranking methodology: rsi14 (lower RSI for buy signals = more oversold/better entry), then adv20_dollars (higher volume = more liquid).
Data overlays:
- Insider flows (buying on crossover adds conviction)
- Earnings proximity (avoid immediate pre-earnings signals)
- Analyst coverage (institutional tracking)
Note: Signals are for educational use and back-testing.
Important: Crossover signals can whipsaw in choppy markets - use with trend confirmation.
📈 Buy-Side Signals (Top 25 of 59 total)
Ranked by RSI (lower RSI for buy signals = more oversold):
| Rank | Ticker | Company | Sector | Last ($) | RSI14 | Insider Net | Days → Earnings | Est EPS | Mkt Cap ($B) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | LEVI | Levi Strauss & Co | Consumer Cyclical | 21.75 | 47.5 | — | 26 | $1.65 | 8.6 |
| 2 | NKE | Nike, Inc. | Consumer Cyclical | 65.92 | 50.7 | — | 68 | $4.25 | 97.4 |
| 3 | VRDN | Viridian Therapeutics,... | Healthcare | 31.75 | 51.2 | $+10.0M | 48 | $3.55 | 2.6 |
| 4 | HSY | The Hershey Company | Consumer Defensive | 189.07 | 51.6 | $-281K | 27 | $10.52 | 38.3 |
| 5 | PNW | Pinnacle West Capital ... | Utilities | 89.07 | 52.5 | — | 46 | $6.59 | 10.7 |
| 6 | ATR | AptarGroup, Inc. | Healthcare | 123.85 | 54.9 | — | 27 | $6.52 | 8.2 |
| 7 | RXO | RXO, Inc. | Industrials | 14.75 | 55.0 | $+489K | 26 | $0.51 | 2.4 |
| 8 | HASI | HA Sustainable Infrast... | Real Estate | 33.46 | 55.3 | — | 34 | $3.85 | 4.2 |
| 9 | NUVL | Nuvalent, Inc. | Healthcare | 105.05 | 55.7 | $-37.2M | 48 | $1.94 | 7.6 |
| 10 | BOOT | Boot Barn Holdings, Inc. | Consumer Cyclical | 195.67 | 56.1 | — | 20 | $9.36 | 6.0 |
| 11 | RXRX | Recursion Pharmaceutic... | Healthcare | 4.66 | 56.5 | $-2.5M | 49 | $-0.94 | 1.9 |
| 12 | NXT | Nextracker Inc. | Technology | 91.17 | 57.1 | $-654K | 18 | $6.77 | 13.5 |
| 13 | TDOC | Teladoc Health, Inc. | Healthcare | 7.46 | 57.2 | $-155K | 47 | $-0.04 | 1.3 |
| 14 | ADP | Automatic Data Process... | Technology | 266.02 | 58.4 | — | 26 | $13.08 | 107.6 |
| 15 | ZBH | Zimmer Biomet Holdings... | Healthcare | 92.85 | 58.4 | — | 27 | $10.65 | 18.4 |
| 16 | EXP | Eagle Materials Inc | Basic Materials | 235.66 | 59.2 | — | 26 | $16.58 | 7.7 |
| 17 | PRIM | Primoris Services Corp... | Industrials | 129.95 | 59.5 | $-2.1M | 45 | $6.98 | 7.0 |
| 18 | ADT | ADT Inc. | Industrials | 8.25 | 59.6 | — | 48 | $0.00 | 6.3 |
| 19 | LPX | Louisiana-Pacific Corp... | Industrials | 92.05 | 60.2 | — | 40 | $0.00 | 6.4 |
| 20 | APA | APA Corporation | Energy | 25.20 | 60.5 | — | 47 | $5.72 | 8.9 |
| 21 | RPM | RPM International Inc. | Basic Materials | 111.02 | 61.4 | — | 87 | $6.79 | 14.2 |
| 22 | PFE | Pfizer, Inc. | Healthcare | 25.48 | 61.9 | — | 25 | $2.30 | 144.9 |
| 23 | ELVN | Enliven Therapeutics, ... | Healthcare | 26.00 | 62.0 | $-900K | 62 | $-2.28 | 1.5 |
| 24 | WPC | W. P. Carey Inc. REIT | Real Estate | 66.50 | 62.4 | — | 32 | $0.00 | 14.6 |
| 25 | NNN | NNN REIT, Inc. | Real Estate | 41.04 | 62.6 | — | 32 | $2.08 | 7.8 |
📉 Sell-Side Signals (20 Total)
Ranked by RSI (higher RSI for sell signals = more overbought):
| Rank | Ticker | Company | Sector | Last ($) | RSI14 | Insider Net | Days → Earnings | Est EPS | Mkt Cap ($B) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ABT | Abbott Laboratories | Healthcare | 125.92 | 54.1 | — | 19 | $7.54 | 219.2 |
| 2 | HCA | HCA Healthcare, Inc. | Healthcare | 472.07 | 54.1 | $-1.8M | 14 | $41.91 | 107.7 |
| 3 | ANET | Arista Networks, Inc. | Technology | 122.89 | 50.7 | $-428K | 39 | $5.99 | 154.7 |
| 4 | DVN | Devon Energy Corporation | Energy | 35.76 | 50.2 | — | 39 | $5.47 | 22.9 |
| 5 | TLN | Talen Energy Corporation | Utilities | 370.83 | 49.6 | — | 48 | $36.80 | 16.9 |
| 6 | ABBV | AbbVie Inc. | Healthcare | 220.08 | 47.1 | — | 21 | $18.93 | 388.9 |
| 7 | RCUS | Arcus Biosciences, Inc. | Healthcare | 21.01 | 44.5 | $-551K | 46 | $0.06 | 2.3 |
| 8 | USFD | US Foods Holding Corp. | Consumer Defensive | 75.59 | 43.3 | — | 34 | $7.85 | 16.9 |
| 9 | ADMA | ADMA Biologics Inc | Healthcare | 17.95 | 41.4 | $-311K | 52 | $1.92 | 4.3 |
| 10 | HIFS | Hingham Institution fo... | Financial Services | 276.57 | 41.4 | — | 90 | $14.04 | 0.6 |
| 11 | ERIC | Ericsson | Technology | 9.34 | 40.7 | — | 14 | $4.72 | 31.1 |
| 12 | KSS | Kohl's Corporation | Consumer Cyclical | 20.54 | 38.5 | $-240K | 60 | $1.32 | 2.3 |
| 13 | ZM | Zoom Communications, Inc. | Technology | 85.18 | 36.3 | $-6.1M | 45 | $6.90 | 25.8 |
| 14 | STLA | Stellantis N.V. | Consumer Cyclical | 10.91 | 34.6 | — | — | $3.63 | 31.5 |
| 15 | KVYO | Klaviyo, Inc. Series A | Technology | 28.58 | 34.5 | $-5.7M | 40 | $1.37 | 8.6 |
| 16 | MGM | MGM Resorts International | Consumer Cyclical | 34.45 | 34.2 | — | 33 | $3.77 | 9.4 |
| 17 | WDFC | WD-40 Company | Basic Materials | 190.00 | 28.9 | $+523K | 87 | $7.35 | 2.6 |
| 18 | TRV | The Travelers Companie... | Financial Services | 281.96 | 25.8 | — | 19 | $28.76 | 63.7 |
| 19 | MLTX | MoonLake Immunotherape... | Healthcare | 18.49 | 21.4 | — | 47 | $-0.17 | 1.2 |
| 20 | BRZE | Braze, Inc. | Technology | 30.07 | 15.1 | $-2.0M | 76 | $0.98 | 3.2 |
Field Notes
Sector concentration: Healthcare (20), Consumer Cyclical (12), Technology (10)
Insider selling: ALKS (Alkermes plc, $-551K), RXRX (Recursion Pharmaceuticals, Inc., $-2.5M), PGY (Pagaya Technologies Ltd., $-315K)
Insider buying: RXO (RXO, Inc., $+489K), SMPL (The Simply Good Foods Company, $+299K), PRMB (Primo Brands Corporation, $+3.2M)
Data coverage: 38.0% insider, 97.5% earnings, 100.0% analyst, 27.8% news
Recent Headlines
Basic Materials
- RPM: RPM Declares Quarterly Dividend (source)
Consumer Cyclical
- STLA: Stellantis (STLA) Stock Dips While Market Gains: Key Facts (source)
- STLA: Stellantis scraps US plug-in hybrid sales, citing weak demand (source)
- STLA: Stellantis scraps Jeep, Chrysler plug-in hybrid vehicles amid EV slowdown, recall (source)
- STLA: BYD Creates New Sub-Brand To Address Ride-Hailing Market: Report (source)
- STLA: Stellantis Italy Output Drops 20% to 379,706 Units as Fiat 500 Hybrid Ramps (source)
- STLA: Stellantis (STLA) Stock Slides as Market Rises: Facts to Know Before You Trade (source)
- STLA: Waymo’s Robo-Taxi Lead Widens as Tesla Plays Catch-Up in the Autonomous Race (source)
- STLA: GM posts 5.5% U.S. sales gain in 2025, Stellantis' Jeep marks first increase in seven years (source)
- STLA: FCA US Fourth-quarter Total Sales Increase 4% Year Over Year; Reports Full-year 2025 US Sales Results (source)
- STLA: Consumer Tech News (Dec 31-Jan 2): Wall Street Braces for Sluggish 2026 Start, AI Spending, and Chip Wars Define Market Pulse & More (source)
- STLA: Tesla Loses Electric Vehicle Crown To China's BYD After Second Year Of Declining Sales (source)
- STLA: Stellantis N.V. $STLA Shares Purchased by Generali Asset Management SPA SGR (source)
Consumer Defensive
- HSY: Hershey (HSY) Outperforms Broader Market: What You Need to Know (source)
- HSY: These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar (source)
- HSY: Hershey to Webcast Fourth-Quarter Conference Call (source)
- HSY: Here Are Wednesday’s Top Wall Street Analyst Research Calls: Applied Digital, BigBear.ai, Block, Deckers Outdoors, GitLab, Hershey, McDonald’s, Moderna, and More (source)
- HSY: Hershey's Pricing Stays Firm: Can HSY's Volumes Stabilize Next? (source)
- HSY: Econ Financial Services Corp Grows Stock Position in Hershey Company (The) $HSY (source)
- HSY: Hershey Company (The) $HSY Stake Lessened by CapWealth Advisors LLC (source)
Energy
- APA: Access Power & Co., Inc. Announces Strategic Expansion of Racks Billiards' Partnership with the APA to Host Major Tournaments Regionally (source)
- APA: Allspring Global Investments Holdings LLC Raises Stock Position in APA Corporation $APA (source)
- APA: Are Select US E&P Stocks Worth a Look Amid Energy Swings? (source)
- APA: APA (APA) Stock Dips While Market Gains: Key Facts (source)
- APA: APA (NASDAQ:APA) & Rock Energy Resources (OTCMKTS:RCKE) Head-To-Head Survey (source)
Healthcare
- ABBV: 2 Healthcare Stocks That Can Diversify a Tech-Heavy Portfolio (source)
- ABBV: Merck Eyes Revolution Medicines in a Potential $32 Billion Deal (source)
- ABBV: Here's What We Expect From AbbVie's Immunology Segment in Q4 (source)
- HCA: 2 Stocks to Buy If the Market Crashes in 2026 (source)
- ABBV: First Look: GM's $7.1B EV Charge, Paramount's $30 WBD Bid (source)
- ABBV: Clear Harbor Asset Management LLC Decreases Stake in AbbVie Inc. $ABBV (source)
- ABBV: Ferguson Wellman Capital Management Inc. Purchases 3,260 Shares of AbbVie Inc. $ABBV (source)
- ABBV: AbbVie Inc. $ABBV Shares Bought by Duncker Streett & Co. Inc. (source)
- ABT: Ferguson Wellman Capital Management Inc. Trims Stake in Abbott Laboratories $ABT (source)
- ABBV: Merck In Talks To Buy Cancer Drug-Maker Revolution Medicines In A $28 To $32 Billion Deal — Stock Soars Overnight (source)
- ABT: The Dividend Aristocrats No One's Talking About (And Their 30+ Year Track Records) (source)
- ABBV: AbbVie: The Dividend Does Not Lie (source)
- ABBV: AbbVie Denies It's in Talks to Buy Revolution Medicines. Both Stocks Are Falling. (source)
- ABBV: Breakfast News: Defense Stocks Whipsaw (source)
- ABBV: AbbVie Inc. $ABBV Stock Holdings Increased by CX Institutional (source)
- ABT: CoreCap Advisors LLC Boosts Stake in Abbott Laboratories $ABT (source)
- ABT: Absolute Software Co. (ABT.TO) (TSE:ABT) Shares Cross Above 200 Day Moving Average – Should You Sell? (source)
- ABBV: Why Revolution Medicines Shares Are Sliding After Hours On Wednesday (source)
- TDOC: Why Teladoc (TDOC) Dipped More Than Broader Market Today (source)
- ATR: Aptar Announces 2026 Quarterly Conference Call Dates (source)
- ABBV: AbbVie in talks to buy biotech Revolution Medicines, WSJ reports (source)
- ABBV: AbbVie Near Deal for Revolution Medicines (source)
- ABT: PBH or ABT: Which Is the Better Value Stock Right Now? (source)
- ABBV: Why Investors Need to Take Advantage of These 2 Medical Stocks Now (source)
- ABT: Abbott: Not Cheap, But Built To Compound In Uncertain Markets (source)
- ABBV: AbbVie to Host Full-Year and Fourth-Quarter 2025 Earnings Conference Call (source)
- ABT: Sentinel Opportunity Fund I Closes Seventh and Eighth Acquisitions with Abbott Laboratories and V3 Engineering, Advancing a Diversified Portfolio Strategy (source)
- ABT: DSM Capital Partners LLC Increases Position in Abbott Laboratories $ABT (source)
- ABT: Cerity Partners LLC Sells 8,052 Shares of Abbott Laboratories $ABT (source)
- ABBV: AbbVie Inc. $ABBV Shares Acquired by Cerity Partners LLC (source)
- ABT: Abbott Laboratories $ABT Shares Sold by First Merchants Corp (source)
- ABBV: What Can Trigger A Breakout In Abbvie Stock? (source)
- ABBV: AbbVie (ABBV) Stock Falls Amid Market Uptick: What Investors Need to Know (source)
- ATR: Aptar to Present at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 (source)
- ABT: Abbott hosts conference call for fourth-quarter earnings (source)
- TDOC: Teladoc Health to Participate in Upcoming Investor Conference (source)
- ABT: Abbott's new Libre Assist app feature tackles a top need for people living with diabetes: in-the-moment food decisions (source)
- ABBV: AbbVie to Present at the 44th Annual J.P. Morgan Healthcare Conference (source)
- ABBV: Railway Pension Investments Ltd Raises Holdings in AbbVie Inc. $ABBV (source)
- ADMA: ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026 (source)
- ABBV: Commonwealth Equity Services LLC Cuts Holdings in AbbVie Inc. $ABBV (source)
- ABBV: AbbVie Inc. $ABBV Holdings Raised by CWA Asset Management Group LLC (source)
- ABBV: 26 Top Dividend Stocks to Buy and Hold in 2026 (source)
- TDOC: 3 Reasons to Forget Teladoc Health Stock (source)
- ABBV: AbbVie: Rocky Near-Term, Positive Long-Term (source)
- ABBV: AbbVie Inc. $ABBV Holdings Lifted by Capital Advisors Inc. OK (source)
- TDOC: Head to Head Comparison: Tauriga Sciences (OTCMKTS:TAUG) & Teladoc Health (NYSE:TDOC) (source)
- ABBV: My Most Important Warning To Dividend Investors For 2026 (source)
- ABBV: Buying This Healthcare Stock Could Make You a Millionaire Retiree (source)
- ABBV: Bell Bank Sells 10,943 Shares of AbbVie Inc. $ABBV (source)
- HCA: Arbor Investment Advisors LLC Makes New $543,000 Investment in HCA Healthcare, Inc. $HCA (source)
- ABBV: Here's How AbbVie's Neuroscience Portfolio Is Aiding Top-line Growth (source)
- ABBV: Generali Asset Management SPA SGR Decreases Stock Holdings in AbbVie Inc. $ABBV (source)
- ABBV: Financial Consulate Inc. Takes $731,000 Position in AbbVie Inc. $ABBV (source)
- ABBV: Banque Pictet & Cie SA Has $77.33 Million Stock Position in AbbVie Inc. $ABBV (source)
Real Estate
- HASI: HASI and Sunrun Expand Long-Term Relationship with New $500 Million Joint Venture to Accelerate Distributed Power Development (source)
Technology
- ADP: 3 Stocks That Benefit if Companies Cut Costs in 2026 (source)
- ADP: First Look: GM's $7.1B EV Charge, Paramount's $30 WBD Bid (source)
- ADP: Ferguson Wellman Capital Management Inc. Acquires 120,671 Shares of Automatic Data Processing, Inc. $ADP (source)
- ADP: The Dividend Aristocrats No One's Talking About (And Their 30+ Year Track Records) (source)
- ADP: 3 Dividend Kings That Are Growing Payouts by 10% or More Each Year (source)
- ANET: 3 Stocks With Analyst Revisions That Could Drive Earnings Surprises (source)
- ADP: First Look: Apple-JPM card deal, Ford L3, defense clampdown (source)
- ANET: Cerity Partners LLC Increases Holdings in Arista Networks, Inc. $ANET (source)
- ADP: Market Today: Trump Housing Ban, Apple Card Shift, ISM Jump (source)
- ADP: ADP Rebounds to +41K, JOLTS & ISM Services After the Open (source)
- ANET: Arista Networks, Inc. (ANET) Is a Trending Stock: Facts to Know Before Betting on It (source)
- ADP: Stock Market Live January 7: S&P 500 (VOO) Rises on Positive Employment Report (source)
- ADP: Gold price continues to see some profit taking as ADP says 41k jobs created in December (source)
- ADP: ADP National Employment Report: Private Sector Employment Increased by 41,000 Jobs in December; Annual Pay was Up 4.4% (source)
- ANET: First Look: Nvidia, Ford, Novo Nordisk and Hyundai in Focus (source)
- ADP: CX Institutional Increases Stake in Automatic Data Processing, Inc. $ADP (source)
- ADP: Automatic Data Processing: Now A Prime Buying Opportunity Gifted By The Market (source)
- ADP: Looking Ahead to a New "Jobs Week" (source)
- ADP: ADP to Announce Second Quarter Fiscal 2026 Financial Results on January 28, 2026 (source)
- ADP: SteelPeak Wealth LLC Sells 31,196 Shares of Automatic Data Processing, Inc. $ADP (source)
- ADP: Once a Market Darling, This Software-as-a-Service Stock Has Been Crushed. Time to Buy? (source)
- ADP: 5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (January 2026) (source)
- ADP: Top 10 High-Yield Dividend Stocks For January 2026 (source)
- NXT: Is Nextpower Stock a Buy Now? (source)
- ADP: Labor Market Data in Focus (source)
- ADP: Generali Asset Management SPA SGR Sells 2,984 Shares of Automatic Data Processing, Inc. $ADP (source)
- ANET: Arista Networks, Inc. $ANET Position Reduced by Braun Stacey Associates Inc. (source)
- ANET: The Real Money in AI Might Be in Power Cooling and Connectivity (source)
Utilities
- TLN: Comparing Fluence Energy (NASDAQ:FLNC) & Talen Energy (NASDAQ:TLN) (source)
- TLN: Talen Energy Corporation $TLN Stake Raised by Osaic Holdings Inc. (source)
Market Context
The broad market advanced today, with the S&P 500 up 0.56%, Nasdaq gaining 0.73%, and Dow Jones rising 0.34%, signaling a bullish trend and healthy risk appetite among investors. For an EMA10/EMA30 crossover strategy, which thrives on sustained directional moves, this upward momentum supports the reliability of signals, particularly long setups as shorter-term EMAs align above longer-term ones in trending conditions. The total of 79 signals reflects active opportunities across the market.
A sharply declining VIX at 14.49, down 7.59%, indicates low volatility and subdued intraday swings, creating a favorable environment for these moving average signals. Reduced noise minimizes false crossovers or whipsaws, allowing EMA10/EMA30 strategies to capture smoother trends without excessive reversals, though traders should remain vigilant for any volatility spikes that could erode edge.
Healthcare emerging as the top sector amid broad gains hints at sector rotation dynamics, potentially drawing flows into relatively stable areas even in a risk-on backdrop. This could amplify signal strength in healthcare for EMA strategies, as defensive rotation bolsters trend persistence, but broad market leadership in growth-oriented indices warrants balanced exposure to avoid overconcentration.
⚠️ Extended Non-Trading Period Alert
Important: The next 2 days (Saturday, January 10 through Sunday, January 11) are non-trading days (weekend/holiday).
What this means:
- Markets will not reopen until Monday, January 12
- News and events occurring over this extended non-trading period may significantly influence market sentiment
- Monitor news flow closely during this period
- Be prepared for potential gaps or increased volatility when markets reopen
- Earnings announcements, geopolitical events, or major news during this period can lead to significant price movements at the open
- Consider adjusting position sizes or using protective stops given the extended gap risk
Vlad's Take (EverHint)
Today's signals: Strong sector concentration in Healthcare (20 signals) suggests sector-specific rotation. 8 signals with insider buying adds conviction. 22 signals showing insider selling warrant caution.
Trading tips for this strategy:
- Entry timing: Enter on pullback after crossover or at crossover close price
- Position sizing: Start with 2-3% of portfolio per signal (swing trade size)
- Stop loss: Below recent swing low for buys, above recent swing high for sells
- Take profit: 5-10% target for swings, or trail stop at EMA10
- Time stop: Exit if crossover reverses within 1-2 weeks (failed signal)
Risk warning: EMA crossovers generate more signals but higher whipsaw risk in ranging markets. Use with trend filter (price vs SMA200)
If you found this useful, a quick like, share, or subscribe keeps EverHint moving forward.
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/